Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
TCG Crossover GP III, LLC RACC Research Alliance Corp III 13G 6.4% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC MCAH Mountain Crest Acquisition 6 Corp. 13G 6.3% 3mo
CITADEL ADVISORS LLC VENU Venu Holding Corp 13G/A 3.8% 3mo
First Trust Capital Management L.P. FMAC Future Money Acquisition Corp 13G/A 3.8% 3mo
AMERIPRISE FINANCIAL INC ERII Energy Recovery, Inc. 13G/A 1.3% 3mo
Squadron Capital Management LLC TRAW Traws Pharma, Inc. 13G/A 0% 3mo
Orbis Investment Management Limited WSE Wise Group plc 13G 5.5% 3mo
LMR Partners LLP MACI Melar Acquisition Corp. I 13G/A 7.8% 3mo
METEORA CAPITAL, LLC CNGL Canna-Global Acquisition Corp. Class A Common Stock 13G/A 19.18% 3mo
Stoney Lonesome HF LP HCAT Health Catalyst, Inc. 13G/A 9.6% 3mo
Twin Lions Management LLC MBUU Malibu Boats, Inc. 13G/A 2.6% 3mo
Harraden Circle Investments, LLC BACC Blue Acquisition Corp 13G 5.1% 3mo
Fort Baker Capital Management LP KBON Karbon Capital Partners Corp. 13G/A 4.2% 3mo
American Century Investment Management, Inc. ATRO Astronics Corp 13G/A 4.5% 3mo
CLEAR STREET LLC WELNF Integrated Wellness Acquisition Corp 13G 12.9% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ IR Ingersoll Rand Inc. 13G/A 6.9% 3mo
Gates Capital Management, Inc. TIC TIC Solutions, Inc. 13G/A 8.8% 3mo
Elliott Investment Management L.P. PINS Pinterest, Inc. 13G 5.8% 3mo
Linden Advisors LP ALF Centurion Acquisition Corp. 13G/A 3.5% 3mo
OSAIC HOLDINGS, INC. RSF RiverNorth Capital & Income Fund, Inc. 13G/A 0.2% 3mo
ADAR1 Capital Management, LLC OKUR OnKure Therapeutics, Inc. 13G/A 5.5% 3mo
Anson Funds Management LP IMPP Imperial Petroleum Inc./Marshall Islands 13G/A 3.6% 3mo
CADIAN CAPITAL MANAGEMENT, LP CYRX Cryoport, Inc. 13G/A 5.8% 3mo
Daniel C. Herz WHK WhiteHawk Minerals Corp. 13G 16.1% 3mo
RTW INVESTMENTS, LP ORKA Oruka Therapeutics, Inc. 13G 5.2% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ RGEN Repligen Corp 13G/A 3.1% 3mo
Anson Funds Management LP LAES SEALSQ Corp 13G/A 4.9% 3mo
CVI Investments, Inc. HTCO High-Trend International Group 13G/A 0% 3mo
Hood River Capital Management LLC RCAT Red Cat Holdings, Inc. 13G 7.16% 3mo
TCG Crossover GP I, LLC TRDA Entrada Therapeutics, Inc. 13G/A 2.7% 3mo
Southpoint Capital Advisors LP XRAY DENTSPLY SIRONA Inc. 13G/A 3.5% 3mo
Castlelake L.P. OPRT Oportun Financial Corp 13G/A 0% 3mo
T. Rowe Price Investment Management, Inc. MPTI M-tron Industries, Inc. 13G 5.9% 3mo
ARK Investment Management LLC TWST Twist Bioscience Corp 13G/A 7.31% 3mo
Berkshire Hathaway Inc DAL Delta Air Lines, Inc. 13G/A 8.7% 3mo
Harraden Circle Investments, LLC ARCL ARC Group Acquisition I Corp. 13G/A 0% 3mo
Balyasny Asset Management L.P. RLYB Rallybio Corp 13G/A 0% 3mo
American Century Investment Management, Inc. CALM Cal-Maine Foods Inc 13G 5.3% 3mo
Point72 Asset Management, L.P. QTTB Q32 Bio Inc. 13G/A 4.95% 3mo
Fourthstone LLC FNRN First Northern Community Bancorp 13G/A 7.01% 3mo
MAK CAPITAL ONE LLC LAB Standard Biotools Inc. 13G/A 7.3% 3mo
QVT Financial LP RAAQ Real Asset Acquisition Corp. 13G 0% 3mo
ALLIANCEBERNSTEIN L.P. VRSK Verisk Analytics, Inc. 13G/A 4.6% 3mo
Divisadero Street Capital Management, LP RSI Rush Street Interactive, Inc. 13G/A 4.7% 3mo
Long Focus Capital Management, LLC AURA Aura Biosciences, Inc. 13G 4.9% 3mo
T. Rowe Price Investment Management, Inc. ALGT Allegiant Travel CO 13G/A 5.2% 3mo
MMCAP International Inc. SPC ASTL Algoma Steel Group Inc. 13G/A 10.4% 3mo
EARNEST PARTNERS LLC NSP Insperity, Inc. 13G/A 8.1% 3mo
CROSSLINK CAPITAL INC IIIV i3 Verticals, Inc. 13G 5.7% 3mo
1607 Capital Partners, LLC GF New Germany Fund Inc 13G/A 5% 3mo